Filing Details
- Accession Number:
- 0001225208-25-002655
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 16:11:53
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 16:11:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2013518 | Emily Woodworth | 300 Boston Scientific Way Marlborough MA 01752-1234 | Svp, Global Controller And Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-28 | 7,218 | $42.16 | 11,519 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-02-28 | 9,887 | $101.13 | 1,632 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2025-03-01 | 837 | $0.00 | 2,469 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-03-01 | 355 | $103.79 | 2,114 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-28 | 7,218 | $0.00 | 7,218 | $42.16 |
Common Stock | Restricted Stock Units | Disposition | 2025-03-01 | 837 | $0.00 | 837 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2030-02-18 | No | 4 | M | Direct | |
2,514 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
- Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant.